GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Eisai Co Ltd (TSE:4523) » Definitions » Other Operating Expense

Eisai Co (TSE:4523) Other Operating Expense : 円-4,516 Mil (TTM As of Dec. 2023)


View and export this data going back to 1961. Start your Free Trial

What is Eisai Co Other Operating Expense?

Eisai Co's Other Operating Expense for the three months ended in Dec. 2023 was 円-1,156 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2023 was 円-4,516 Mil.

Eisai Co's quarterly Other Operating Expense increased from Jun. 2023 (円-242 Mil) to Sep. 2023 (円376 Mil) but then declined from Sep. 2023 (円376 Mil) to Dec. 2023 (円-1,156 Mil).

Eisai Co's annual Other Operating Expense declined from Mar. 2021 (円1,171 Mil) to Mar. 2022 (円-10,523 Mil) but then increased from Mar. 2022 (円-10,523 Mil) to Mar. 2023 (円-4,765 Mil).


Eisai Co Other Operating Expense Historical Data

The historical data trend for Eisai Co's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Eisai Co Other Operating Expense Chart

Eisai Co Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Other Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only -866.00 -1,987.00 1,171.00 -10,523.00 -4,765.00

Eisai Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Other Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -201.00 -3,494.00 -242.00 376.00 -1,156.00

Eisai Co Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円-4,516 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Eisai Co Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Eisai Co's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Eisai Co (TSE:4523) Business Description

Traded in Other Exchanges
Address
4-6-10 Koishikawa, Bunkyo-ku, Tokyo, JPN, 112-8088
Eisai Co Ltd is a specialty and generic drug manufacturing company. The company's business consists of a pharmaceutical business and other businesses. The pharmaceutical business is categorized by region, including Japan, Americas, China, Asia, and Europe, Middle East, and Africa. Eisai also reports a consumer healthcare business for Japan. The vast majority of the company's revenue is derived by its Japanese pharmaceutical business, followed by its Americas pharmaceuticals segment. The company utilizes licensing strategies in order to expand its research, development, manufacturing, and marketing capabilities.

Eisai Co (TSE:4523) Headlines

No Headlines